Presentations of intoxicated patients to hospital are frequent and increasing. We aimed to review the existing evidence that the presence of inpatient clinical toxicology services reduces use of resources without impacting on the care of these patients.
Introduction
Despite improvements in service provision and care, intoxication, and specifically deliberate self-poisoning (DSP), remains a common presenting complaint to emergency departments, with significant morbidity and mortality. In 2016/17, there were 181 143 cases of poisoning (including overdose) in EDs across the UK [1] , with other recent studies measuring age-standardized rates of between 355 and 549 per 100 000 per year in a UK tertiary centre [2] .
These rates show that DSP creates a significant burden on resources, not least from the toxicology aspect of their care. There are multiple reasons for this (longer periods of hospital stay, additional nursing input, additional investigations), much of which stem from the clinical uncertainty such patients can pose. It has even been demonstrated that such patients consume more ED resources than other similar patients on average [3] . In addition, such clinical uncertainty can also lead to heterogeneity in the management of these patients, with significant variation between otherwise similar hospitals in this regard [4] .
One such model that could be used to address these issues is that of resident toxicologists, available not only to provide consultation on such patients to specialist teams, but also to directly admit patients under their care, in order to better streamline and co-ordinate their management. Amongst others, Australia, Hong Kong and the United States have adopted this model (some alongside the existence of poisons information services), and report benefits with respect to resource consumption, without detriment to patient outcomes. The UK service is structured similarly, with four poisons centres (Birmingham, Cardiff, Edinburgh and Newcastle), and toxicologists also posted in London and York. In addition to providing a local service (including inpatient management), consultant clinical toxicologists in the UK also provide 24-hour telephone advice services to medical staff in other hospitals [5, 6] .
In this review, we will assess the existing literature on the topic, to determine whether having resident toxicology teams leads to better resource utilization, as determined by length of admission/stay, and other secondary outcomes. With such a benefit, an argument can be made for expanding the current network beyond its current size and the six aforementioned centres, a topic that has already been previously discussed [6] .
The clinical question that we aim to address is: Does the use of toxicology units (intervention) improve the length of stay (outcome) for patients attending hospital with intoxication (population)?
Methods
Both authors devised systematic search strategies for the Cochrane database, MEDLINE and Embase. The keywords, operators, and terms used were: The searches for each database were conducted up to 4 April 2018. There was no 'published after' criterion. In addition, each relevant article found using the above strategies was screened by hand as a secondary source for further articles.
At this point, duplicates were removed and the reports found were then screened by the authors for relevance, and then according to eligibility criteria. To be included, the article must be a systematic review/randomized controlled trial (RCT)/analytical or cross-sectional study, it must include hospital length of stay as one of its primary or secondary outcomes and it must include inpatient toxicology services with admitting rights as one of its interventions. Articles were limited to those in English (or with an English translation), and those with full-text availability.
Each article was then assessed by R.L. for bias using the ROBINS-I tool [7] . Details of this analysis can be found in Table 1 . Further discussion of the risk of bias across studies can be found in the discussion. The level of evidence for each article was graded using the NHMRC scale. Each stage of the review was conducted with reference to PRISMA guidelines [8] .
Results
The initial search identified zero results from the Cochrane library, 1577 results from MEDLINE, and 2528 results from This US study is limited by its retrospective nature and low study population. The case control approach is used well, controlling for severity of overdose (as judged by signs/symptoms).
Overall low/moderate risk of bias, worse for secondary outcomes due to confounders and variable reporting. The use of a second phase controls somewhat for potential confounders during the longitudinal phase.
However, focus on TCA overdose patients, and in particular excluding polypharmacy overdoses, limits the applicability of study. It also limits (continues) Reduction in TCA levels (32%), and full blood count (18%)
Reduction in gastric lavage (61%) and Mg citrate (42%) the population, reducing statistical power.
Generation of simulated repetitions to increase statistical power potentially amplifies any biases. It is also unclear where these have been used, and the exact method.
No improvement in primary outcome, but benefit in other resource-related outcomes. However, evaluation of many outcomes increases overall risk of type I error in study. CIs are provided. Significant overall benefits. First study to include accidental intoxication, and also to clearly define complex patients, demonstrating greater benefit for them.
However, admission criterion of >12 h expected stay may explain the lack of benefit to ED LoS, as no toxicology service formally provided for short cases. Significant time gap in studied groups allows for potential confounders, such as noted introduction of improved pathology services.
The toxicology service was only involved in 53% of cases in the intervention group.
(continues) 
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Embase. There was overlap between the MEDLINE and Embase results, with 2428 reports remaining after removal of duplicates. After screening each report for relevance, seven articles remained. This reflected the difficulty the authors had, given the relatively non-specific nature of the search terms involved in the inquiry, resulting in a large number of articles failing to meet the threshold for relevancy to the topic. However, whilst relatively non-specific, this strategy was felt best so as to maximize the likelihood of including all relevant articles.
Full-text copies were available for each of the relevant seven articles, and all met the initial inclusion criteria described above. Figure 1 summarizes the article selection process.
Each article was then designated an NHMRC level of evidence rating [9] , and a 'risk of bias' rating as per the Figure 1 Flow diagram summarizing the selection of articles ROBINS-I tool [7] . Table 1 provides the outcomes and results from each article, as well as individual commentary and the risk of bias assessment for each.
Length of stay
All of the articles had length of stay as one of their outcomes.
Six of the papers consistently demonstrated a reduction in overall hospital length of stay -some by comparison to data with previous services [10] [11] [12] , some by comparison to a local hospital [13, 14] or regional/national average [15] . However, one article reported no such effect, though the original data for this outcome was not provided [16] . Some articles further analysed their data with respect to complexity of patient -this was performed either by creating 'non-complex' and 'complex' subsets [10, 11] , or through novel calculated outcomes that incorporated a patient's complexity [15] . Regardless of the method used, improvements in hospital length of stay were demonstrated across all articles, often with greater benefit than for the overall population.
Two papers recorded ED length of stay as a separate outcome measure, with one demonstrating no significant change [11] , and one demonstrating a prolonged ED length of stay when inpatient toxicology services were formed [12] .
Morbidity and mortality
Four articles reported specifically on this outcome. Two of the articles reported no change in mortality after initiation of inpatient toxicology services [10, 14] , and one article reported no change in patient outcomes and no change in ED reattendance or hospital admission [12] . However, one article (that contemporaneously compared between sites and teams) reported that patients managed at a specialist centre by an inpatient toxicology team had a lower mortality than expected, by up to 5.48%, significantly more than other cohorts [13] .
Other outcomes
Throughout the seven articles, a number of other outcomes related to resource use were reported. There were mixed outcomes for hospital admission, with one article suggesting it was increased [11] , but two more recent articles suggesting inpatient toxicology services decreased admissions [12, 14] . Similarly, with respect to ICU resources, one article reported reduced admission to ICU [16] , but three others reported increased ICU input/admission to varying levels of significance [11, 12, 14] .
One article focused on toxicology-related investigations and interventions (e.g. gastric lavage) [16] . They reported an overall reduction in lab tests ordered under toxicology teams, with the exception of paracetamol level testing. Additionally, there was an overall reduction in acute toxicology interventions provided.
Three of the articles calculated an estimated saving based on their data, with one commenting on the difficulty in doing so [10] . These estimates included AUD1.39 million for the period 1994-95 [10] , USD4.269 million for the period 2010-11 [13] , and AUD2.25 million for the period 2014-15 [15] . Their variability likely reflects the changes in cost of resources with time and difference in healthcare system between the articles.
One article directly assessed the cost involved with each case in their study, reporting a reduction in cost per case under toxicology teams of between USD1016 and USD1798 (depending on diagnosis-related group), with no such reduction in other cohorts [13] .
Discussion
Whilst there are variations in methodology and size of effect, there is a consistent finding across the examined articles, that the presence of inpatient toxicology services in a hospital reduces overall length of stay for patients suffering from intoxication, but potentially at the expense of longer ED length of stay. This effect was also demonstrated when the results were compared to other similar types of presentation [13, 15] and controls in hospitals without such toxicology services [13, 14] .
The reasons for this effect are multi-factorial, such as centralized services, earlier delineation of patients with nonsignificant exposures (thus reducing need for diagnostics and observation), and a more efficient use of multidisciplinary team (MDT) services, particularly in those units with psychiatric input [10] . This latter factor is notable, as defined MDT input was not described in [16] , one of the articles to demonstrate no improvement in length of stay.
It is also worth noting that some articles demonstrated an enhanced effect on length of stay for complex patients [11, 13] . This may be in part due to a reduction in fragmentation of services, by having a lead toxicologist for each case, rather than the varied input of multiple medical teams. Fragmentation of services has been shown to increase length of stay in a general hospital setting for other diagnoses [17] and so a similar effect is likely applicable here.
Additionally, some of the articles assessed other markers of resource utilization. One such article showed a reduction in toxicology-related investigations and interventions [16] , which may represent the more tailored and specialist approach that an inpatient toxicology service could provide, saving cost spent on otherwise unnecessary tests and interventions. However, there were mixed results with respect to admissions to hospital and ICU (a possible surrogate marker for streamlining of care by specialist teams): there was no consistent direction or size for this outcome, with both increases and decreases in ICU input [11, 12, 14, 16] and hospital admissions [11, 12, 14] . This may reflect the differences between the centres in non-toxicology service provision, community services available and relative risk of patient groups involved. One would expect, however, that with further development of toxicology services and analysis of outcome data, protocols could be devised that may better streamline cases to the appropriate location of care.
However, one confounder that must be noted is the use of short-stay wards in ED, a development that has significantly changed the management of a number of patient categories, including intoxicated patients. A number of the centres involved in this review made use of short-stay wards in addition to toxicology services, and an independent effect of shortstay wards has previously been demonstrated in intoxicated patients [18, 19] . Indeed, it has also been demonstrated that stepping down patients from ICU to an ED short-stay ward, with the assistance of an inpatient toxicology team, can significantly reduce ICU length of stay [20] .
Despite these significant findings, this review has limitations. One such limitation relates to the method of literature search, in that, given the somewhat non-specific terms in the research question (particularly those defining a toxicology inpatient team), it is possible that despite large returns for such terms, some articles may still have been omitted.
Additional limitations stem from the methodologies of the studies themselves. In particular, all of the studies are observational (though it would be difficult to envisage how one could construct a logistically-and ethically-sound RCT for this query), and the majority are retrospective in nature, and thus unable to demonstrate a causal relationship. Some of the studies also involve a long period of time between study and control groups, which increases the likely influence of additional confounding factors [10, 12, 16] .
Whilst the articles reviewed have an overall low/moderate bias risk, it is worth considering these sources of bias. For instance, some of the data in these studies collected by independent bodies (e.g. Health Round Table) is based on discharge diagnoses, risking ascertainment bias, in that we are unable to apply these findings to patients who on presentation may be intoxicated (and thus be managed by toxicology), but have unclear or alternate diagnoses on discharge. This is a significant subset of patients for whom the outcomes must also be known. However, the use of quantitative and objective outcomes minimizes other forms of bias (e.g. observer and recall), though those that have been manipulated to provide an estimate (such as the relative stay index [15] ) may well introduce estimator bias if not all significant patient and system factors are accounted for.
Because of the varied source and methodologies of the included articles, there are some caveats with respect to this review's applicability. For instance, the articles are drawn from healthcare systems from three different countries that may in themselves also have regional variations. Whilst there are similarities between the systems, there will also be systematic differences that limit the cross-comparison of results. This is further compounded by differences in methodology between the studies (such as in measurement of length of stay, inclusion/exclusion criteria, etc). Notably, some of the articles limit themselves only to self-poisoning (or subsets thereof), which must be considered when applying the findings to the whole population of intoxicated patients, though one would imagine similar effects would be seen.
Additionally, when considering the results of this review and how they might apply in practice, the financial implications require further analysis. Despite focusing on resource use, only three of the articles calculated an estimated saving based on their data, which was largely based on difference in length of stay between cohorts. One article commented on the difficulty in providing more accurate and detailed estimates [10] .
Furthermore, whilst the potential savings have been estimated in some of the articles, none ventured to discuss or estimate the cost (beyond a one-off figure stated for a toxicology consult at the University of California, San Diego Medical Centre, of USD150 [16] ). This reflects the difficulty with assessing the large number of variables involved, as in addition to toxicology clinician time, additional personnel costs (administrative and nursing), laboratory costs, transport/retrieval costs, and medication/antidote costs, to name but a few, would all need to be factored in. As with potential savings, these will all again vary considerably from healthcare system to system, and with current provision of services. Thus, providing a summary estimate, in the face of such variability and absence of provided figures in the subject articles, becomes incredibly difficult. However, this does limit the applicability of our findings, as each individual health service would need to consider these costs when estimating the benefit of developing a toxicology service.
Conclusion
It appears that despite some methodological flaws, there is a consistent and varied evidence base to support inpatient toxicology services significantly reducing resource consumption (particular bed space/time) without compromising patient outcomes, at a time when hospital resources are becoming more stretched.
However, the training pathway and model for toxicology differs greatly in the UK compared to Australia and Hong Kong. As such, due consideration for how to develop the specialty structure alongside existing specialties, without deskilling them, is needed (and indeed such a consideration has been previously discussed [6] , as well as incorporating existing toxicology resources (such as professional helplines), and considering the costs of such development).
